WVE Wave Life Sciences Ltd. Stock Quote

WVE [NASD]

Index	-	P/E	-	EPS (ttm)	-5.05	Insider Own	1.50%	Shs Outstand	38.36M	Perf Week	10.13%
Market Cap	522.19M	Forward P/E	-	EPS next Y	-1.64	Insider Trans	-14.26%	Shs Float	21.19M	Perf Month	5.26%
Income	-177.90M	PEG	-	EPS next Q	-0.61	Inst Own	74.90%	Short Float	20.67%	Perf Quarter	15.60%
Sales	13.00M	P/S	40.17	EPS this Y	-12.90%	Inst Trans	-2.79%	Short Ratio	7.29	Perf Half Y	-14.22%
Book/sh	2.82	P/B	3.80	EPS next Y	58.10%	ROA	-68.60%	Target Price	-	Perf Year	34.99%
Cash/sh	4.44	P/C	2.41	EPS next 5Y	-	ROE	-377.80%	52W Range	6.61 - 19.98	Perf YTD	36.02%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-327.00%	52W High	-46.42%	Beta	0.37
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	-	Gross Margin	-	52W Low	61.95%	ATR	0.69
Employees	301	Current Ratio	2.40	Sales Q/Q	20.70%	Oper. Margin	-	RSI (14)	57.89	Volatility	7.51% 6.79%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	41.70%	Profit Margin	-	Rel Volume	1.24	Prev Close	10.03
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 04 BMO	Payout	-	Avg Volume	601.02K	Price	10.70
Recom	2.40	SMA20	2.42%	SMA50	11.03%	SMA200	8.73%	Volume	744,953	Change	6.73%

Dec-15-20

Resumed

H.C. Wainwright

Buy

$20

Oct-23-20

Initiated

RBC Capital Mkts

Sector Perform

$13

Dec-31-19

Downgrade

SVB Leerink

Outperform → Mkt Perform

$33 → $10

Nov-01-19

Initiated

Guggenheim

Buy

$43

Jul-15-19

Initiated

Cowen

Market Perform

Apr-17-19

Reiterated

H.C. Wainwright

Buy

$49 → $33

Aug-07-18

Initiated

Stifel

Buy

$56

Jul-23-18

Initiated

H.C. Wainwright

Buy

$49

Mar-19-18

Reiterated

Mizuho

Buy

$34 → $65

Feb-15-17

Initiated

H.C. Wainwright

Buy

$41

Nov-10-16

Resumed

Leerink Partners

Outperform

Dec-07-15

Initiated

Sun Trust Rbsn Humphrey

Buy

$26

Dec-07-15

Initiated

Leerink Partners

Outperform

$20

Dec-07-15

Initiated

JMP Securities

Mkt Outperform

$52

Dec-07-15

Initiated

Jefferies

Buy

$28

Feb-23-21 08:00AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021 GlobeNewswire
Feb-16-21 05:00PM	Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-08-21 10:11AM	10 Best Small-Cap Biotech Stocks Under $10 in 2021 Insider Monkey
Jan-12-21 08:47AM	Wave Life Sciences' (NASDAQ:WVE) Shareholders Are Down 74% On Their Shares Simply Wall St.
Jan-11-21 08:00AM	Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications GlobeNewswire -6.96%
Dec-02-20 08:00AM	Wave Life Sciences Announces Appointment of Jonathan Rosin as Chief Human Resources Officer GlobeNewswire
Nov-12-20 08:11AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates Simply Wall St.
Nov-10-20 08:00AM	Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference GlobeNewswire
07:44AM	Analysts Are Betting On Wave Life Sciences Ltd. (NASDAQ:WVE) With A Big Upgrade This Week Simply Wall St.
Nov-09-20 05:30PM	WAVE Life Sciences Pte. Ltd. (WVE) Q3 2020 Earnings Call Transcript Motley Fool
08:55AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates Zacks
08:14AM	WAVE Life Sciences: Q3 Earnings Insights Benzinga
07:30AM	Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
06:30AM	Wave Life Sciences Ltd. to Host Earnings Call ACCESSWIRE
Nov-02-20 12:31PM	Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-26-20 04:05PM	Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020 GlobeNewswire
Oct-23-20 10:48AM	Benzinga's Top Upgrades, Downgrades For October 23, 2020 Benzinga
Sep-28-20 04:05PM	Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference GlobeNewswire
Sep-23-20 10:02AM	Unusual Options Activity Insight: WAVE Life Sciences Benzinga -36.74%
07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares GlobeNewswire
Sep-22-20 04:19PM	Why Wave Life Sciences Shares Vaulted Higher Today Motley Fool +5.25%
04:01PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares GlobeNewswire
Sep-16-20 09:14AM	Implied Volatility Surging for Wave Life Sciences (WVE) Stock Options Zacks +8.25%
Sep-15-20 08:20AM	Companies Like Wave Life Sciences (NASDAQ:WVE) Could Be Quite Risky Simply Wall St. +11.98%
07:30AM	Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual Meetings GlobeNewswire
Sep-10-20 04:25PM	Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire
Aug-10-20 09:30PM	WAVE Life Sciences Pte. Ltd. (WVE) Q2 2020 Earnings Call Transcript Motley Fool
08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:11AM	WAVE Life Sciences: Q2 Earnings Insights Benzinga
07:30AM	Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Aug-06-20 08:00AM	Wave Life Sciences to Highlight PRISM Platform Advancements and Preclinical Neurology Pipeline During Analyst and Investor Research Webcast GlobeNewswire
Aug-03-20 12:31PM	Will Wave Life Sciences (WVE) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-27-20 04:05PM	Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020 GlobeNewswire
12:31PM	Will Wave Life Sciences (WVE) Report Negative Q2 Earnings? What You Should Know Zacks
Jun-24-20 08:46AM	Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock? Zacks
Jun-18-20 05:14PM	Edited Transcript of WVE earnings conference call or presentation 11-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-26-20 04:05PM	Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference GlobeNewswire
May-18-20 07:30AM	Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery GlobeNewswire
May-11-20 07:01PM	WAVE Life Sciences Pte. Ltd. (WVE) Q1 2020 Earnings Call Transcript Motley Fool +26.85%
08:55AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates Zacks
07:53AM	Recap: WAVE Life Sciences Q1 Earnings Benzinga
07:30AM	Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Apr-29-20 04:05PM	Wave Life Sciences to Webcast Conference Call of First Quarter 2020 Financial Results on May 11, 2020 GlobeNewswire -6.67%
Apr-23-20 07:01PM	Cambridge biotech to return its PPP loan American City Business Journals
Apr-22-20 06:35PM	Are Paycheck Protection Loans Good for Publicly Traded Companies? GuruFocus.com
Mar-24-20 10:38AM	Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT Thomson Reuters StreetEvents
Mar-02-20 07:55AM	Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates Zacks -6.04%
06:45AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire
Feb-26-20 11:55AM	Is Wave Life Sciences Ltd.'s (NASDAQ:WVE) CEO Being Overpaid? Simply Wall St.
Feb-24-20 12:30PM	Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for Zacks -7.42%
Feb-19-20 08:00AM	Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference GlobeNewswire
Feb-18-20 08:00AM	Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntingtons Disease Program at CHDI Foundations 15th Annual HD Therapeutics Conference GlobeNewswire
Feb-13-20 08:05AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 GlobeNewswire
Jan-22-20 11:48AM	New FDA documents shed light on agency's rejection of Sarepta drug American City Business Journals
Jan-16-20 09:39AM	Wave Life Sciences Enters Oversold Territory Zacks
Jan-14-20 09:55AM	Wave Life Sciences Enters Oversold Territory Zacks
Dec-31-19 06:10AM	Experts question Cambridge biotech's strategy after trial failure American City Business Journals
Dec-30-19 04:10PM	Why This Biotech Stock Had Two Devastating Crashes This Month Investor's Business Daily -49.46%
07:00AM	Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntingtons Disease GlobeNewswire
06:24AM	Wave Life Sciences Shares Off by Half After Disappointing Trial for Huntington Disease TheStreet.com
Dec-24-19 12:18PM	Here's Why We're Watching Wave Life Sciences's (NASDAQ:WVE) Cash Burn Situation Simply Wall St.
Dec-23-19 09:52AM	Options Traders Expect Huge Moves in Wave Life Sciences (WVE) Stock Zacks
Dec-16-19 04:09PM	Why This Biotech's 55% Plunge Will Ultimately Benefit Its Biggest Rival Investor's Business Daily -55.35%
02:37PM	Wave Life Sciences Stock Folds on Drug Decision Schaeffer's Investment Research
09:27AM	Cambridge biotech's stock price tumbles on Duchenne drug failure American City Business Journals
07:00AM	Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy GlobeNewswire
Dec-11-19 02:21PM	Did Hedge Funds Drop The Ball On WAVE Life Sciences Ltd. (WVE) ? Insider Monkey
Dec-06-19 02:23PM	Hedge Funds Love Liberty Tripadvisor (LTRPA) Way More Than These 3 Stocks Insider Monkey
Nov-14-19 10:02AM	Implied Volatility Surging for Wave Life Sciences (WVE) Stock Options Zacks
Nov-06-19 12:15PM	If You Had Bought Wave Life Sciences (NASDAQ:WVE) Stock A Year Ago, You'd Be Sitting On A 40% Loss, Today Simply Wall St.
Nov-05-19 07:15PM	Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:05PM	Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Nov-01-19 10:30AM	Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-28-19 02:13PM	Is WAVE Life Sciences Ltd. (WVE) Going To Burn These Hedge Funds ? Insider Monkey +7.74%
Sep-18-19 02:12PM	Are Insiders Selling Wave Life Sciences Ltd. (NASDAQ:WVE) Stock? Simply Wall St.
Sep-16-19 07:30AM	Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen GlobeNewswire +14.45%
Sep-06-19 08:30AM	Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 GlobeNewswire -5.53%
Aug-26-19 04:05PM	Wave Life Sciences to Present at the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-20-19 12:20PM	Sarepta's FDA rejection could have ripple effect in other Duchenne biotechs American City Business Journals
Aug-06-19 07:30AM	Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer GlobeNewswire
Jul-29-19 07:05PM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates Zacks -8.55%
04:05PM	Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Jul-17-19 03:23PM	Is Wave Life Sciences Ltd. (NASDAQ:WVE) Overpaying Its CEO? Simply Wall St.
Jul-01-19 09:35AM	Sarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues Zacks
Jun-27-19 08:00AM	Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen GlobeNewswire
08:00AM	Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer GlobeNewswire
Jun-12-19 08:00AM	Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference GlobeNewswire
Jun-06-19 06:10PM	Vertex enters Duchenne field with $245M buy of Exonics American City Business Journals
May-10-19 08:45AM	Wave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:42AM	Wave Life Sciences: 1Q Earnings Snapshot Associated Press
07:30AM	Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
May-02-19 02:18PM	Is WAVE Life Sciences Ltd. (WVE) A Good Stock To Buy ? Insider Monkey
May-01-19 10:33AM	Wave Life Sciences (WVE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-23-19 12:23PM	What Are Analysts Saying About Wave Life Sciences Ltd.'s (NASDAQ:WVE) Earnings Trajectory? Simply Wall St.
Apr-17-19 11:10AM	Wave Life Sciences Plunges After DMD Study Data Readout Zacks +6.29%
07:48AM	The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 05:17PM	Qualcomm and Progressive jump while Wave Life Sciences drops Associated Press -28.07%
12:14PM	Why Wave Life Sciences's Valuation Is Falling By 25% Benzinga
07:00AM	Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design GlobeNewswire
Apr-13-19 09:38AM	The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Benzinga

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Francis Chris	See Remarks	Feb 16	Sale	10.57	2,698	28,518	78,462	Feb 18 07:26 PM
BOLNO PAUL	President and CEO	Feb 16	Sale	10.57	11,205	118,437	410,976	Feb 18 07:18 PM
Panzara Michael A.	See Remarks	Feb 16	Sale	10.57	2,929	30,960	86,420	Feb 18 07:16 PM
Vargeese Chandra	Chief Technology Officer	Feb 16	Sale	10.57	3,145	33,243	85,412	Feb 18 07:14 PM
Moran Kyle	Chief Financial Officer	Feb 16	Sale	10.57	1,722	18,202	69,862	Feb 18 07:09 PM
BOLNO PAUL	President and CEO	Sep 15	Option Exercise	2.48	100,000	248,000	372,181	Sep 17 09:10 PM
BOLNO PAUL	President and CEO	Sep 15	Sale	15.00	100,000	1,500,000	272,181	Sep 17 09:10 PM
BOLNO PAUL	President and CEO	Aug 25	Option Exercise	2.48	25,000	62,000	297,181	Aug 27 06:44 PM
BOLNO PAUL	President and CEO	Aug 25	Sale	12.00	25,000	300,000	272,181	Aug 27 06:44 PM
BOLNO PAUL	President and CEO	Jul 02	Option Exercise	2.48	100,000	248,000	372,181	Jul 02 08:56 PM
BOLNO PAUL	President and CEO	Jul 02	Sale	10.30	147,577	1,520,276	272,181	Jul 02 08:56 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience